These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5961405)

  • 21. The assessment of the functional capacity of the hypothalamic-pituitary-adrenal axis by measurement of basal plasma and urinary cortisol in comparison with insulin-induced hypoglycaemia and metyrapone tests.
    de Lange WE; Sluiter WJ
    Neth J Med; 1993 Aug; 43(1-2):64-8. PubMed ID: 8232696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of metandiennone (Geabol, Dianabol) on pituitary function].
    Sparrevohn S; Friis T
    Ugeskr Laeger; 1966 Feb; 128(6):171-7. PubMed ID: 4164016
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of an adrenocortical inhibitor on urinary 17-ketogenic levels and on water-salt exchange. (Metopirone test. Experimental studies)].
    Cocuzza S; Ferrari G; De Sanctis C; Cattaneo G
    Minerva Pediatr; 1969 Jun; 21(26):1197-203. PubMed ID: 4324691
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypothalamic-pituitary-adrenal (HPA) function in adrenocortical steroid treated minimal change nephrotic syndrome.
    Moel DI; Kwun YA; Teitcher J
    Clin Nephrol; 1980 Jul; 14(1):36-41. PubMed ID: 6250751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Night suppression with high doses of dexamethasone and metyrapone tests for the etiological diagnosis of Cushing syndrome].
    Rossi MA; Chervin RA; Bruno OD
    Medicina (B Aires); 1996; 56(5 Pt 1):455-62. PubMed ID: 9239880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metopirone test (450 tests on 360 subjects)].
    Chalendar D; Tourniaire J; Orgiazzi J; Revol A; Guinet P
    Lyon Med; 1972 Jun; 227(12):1201-9. PubMed ID: 4644376
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests.
    Giordano R; Picu A; Bonelli L; Balbo M; Berardelli R; Marinazzo E; Corneli G; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):935-41. PubMed ID: 18031311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth retardation in thalassemia major.
    Zaino EC; Kuo B; Roginsky MS
    Ann N Y Acad Sci; 1969 Nov; 165(1):394-9. PubMed ID: 5260161
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Metopirone test in the course of ganglio-pulmonary sarcoidosis].
    Brun J; Perrin-Fayolle M; Revol A
    Mars Med; 1966; 103(11):815-26. PubMed ID: 5991814
    [No Abstract]   [Full Text] [Related]  

  • 30. [Excretion of 17-ketosteroids and Thorn's test in chemical burns of the digestive tract].
    Zhukov MD; Bondarenko AZ
    Sov Med; 1970 Feb; 33(2):23-7. PubMed ID: 5457143
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous metyrapone test.
    Kålund Jensen H; Blichert-Toft M
    Dan Med Bull; 1972 May; 19(3):85-8. PubMed ID: 5023115
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of the metopirone test in the determination of hypophyseal corticotropin reserve. Changes in urinary 17-hydroxycorticosteroids induced by metopirone (SU 4885) in subjects with suspected disorders of the adenohypophyseal function. Our 1st experience].
    Nedok A
    Srp Arh Celok Lek; 1966 Dec; 94(12):1085-93. PubMed ID: 5980389
    [No Abstract]   [Full Text] [Related]  

  • 33. [The metyrapone test in bronchial asthma].
    Langer-Costanzi M; Ciardi-Dupré GF
    Folia Allergol (Roma); 1966; 13(4):269-79. PubMed ID: 5990234
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial moniliasis, defective delayed hypersensitivity, and adrenocorticotropic hormone deficiency.
    Castells S; Inamdar S; Orti E
    J Pediatr; 1971 Jul; 79(1):72-9. PubMed ID: 5091270
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of adrenal-pituitary function by means of methopyrone test in healthy children and in children under corticosteroid therapy].
    Massolo F; Galli V; Balli F; Di Battista C
    Minerva Pediatr; 1969 Dec; 21(51):2407-10. PubMed ID: 5405120
    [No Abstract]   [Full Text] [Related]  

  • 36. Critical evaluation of the 5-day metyrapone test.
    Leisti S; Perheentupa J
    Horm Res; 1977; 8(1):1-22. PubMed ID: 196992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of patients with Cushing's syndrome before and after pituitary implantation.
    Hartog M; Joplin GF; Fotherby K; Mattingly D; Fraser TR
    Proc R Soc Med; 1967 Sep; 60(9):911. PubMed ID: 6059077
    [No Abstract]   [Full Text] [Related]  

  • 38. [Attempt of evaluation of efficiency of the adrenal cortex in typhoid fever].
    Adamczyk J
    Przegl Epidemiol; 1967; 21(1):7-18. PubMed ID: 6044685
    [No Abstract]   [Full Text] [Related]  

  • 39. Metyrapone test during gangliopulmonary sarcoidosis.
    Nielsen EG
    Dis Chest; 1968 Jun; 53(6):722-5. PubMed ID: 5653746
    [No Abstract]   [Full Text] [Related]  

  • 40. [ACTH response to 24 hours oral metyrapone test in normal children (author's transl)].
    Delepine N; Desbois JC; Techenet J; Gueris J; Herrault A
    Sem Hop; 1980 May 18-25; 56(19-20):946-50. PubMed ID: 6251560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.